Twist Bioscience Corp (TWST : NASDAQ)
Common Stock
$142.70
USD
+0.00 (%)
Last updated: 2026-10-21
Follow TWST
TWST
Twist Bioscience Corp
WealthAwesomePerformance
1 Day
+2.10%
1 Week
-5.70%
1 Month
-14.55%
YTD
+72.20%
Key Statistics
Market Cap
$9.46B
52W High
$219.71
52W Low
$23.30
P/E Ratio
-
50 Day MA
$148.75
200 Day MA
$84.35
Beta
2.19
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/21/2026 | $139.34 | $153.80 | $138.25 | $149.13 | $149.13 | 2,632,441 |
| 10/20/2026 | $139.77 | $148.83 | $134.94 | $142.70 | $142.70 | 2,005,439 |
| 10/19/2026 | $136.99 | $141.80 | $133.72 | $139.77 | $139.77 | 1,591,136 |
| 10/16/2026 | $143.88 | $145.05 | $130.98 | $132.75 | $132.75 | 2,826,600 |
| 10/15/2026 | $138.09 | $148.32 | $130.68 | $144.49 | $144.49 | 3,542,965 |
| 10/14/2026 | $146.69 | $156.00 | $144.79 | $148.16 | $148.16 | 2,113,530 |
| 10/13/2026 | $149.00 | $154.23 | $146.00 | $151.33 | $151.33 | 1,529,594 |
| 10/12/2026 | $159.78 | $161.80 | $147.55 | $151.86 | $151.86 | 2,232,851 |
| 10/9/2026 | $152.69 | $168.93 | $152.14 | $159.78 | $159.78 | 3,540,000 |
| 10/8/2026 | $148.00 | $152.59 | $144.60 | $152.05 | $152.05 | 4,227,213 |
Analyst Price Targets
Based on 13 analysts covering TWST · as of Oct 14, 2026
Wall Street analysts forecast TWST stock price to rise 14.7% over the next 12 months.
Consensus
Buy4.08 / 5.00
Avg. Target
US$163.67
+14.7% Upside
Previously US$157.42 on Oct 13, 2026
Current Price
US$142.70
Last close
Analyst Breakdown (13 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TWST's historical volatility
30-Day Vol
100.7%
Annualized
90-Day Vol
91.7%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$178.29
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$158.28 | US$111.81 – US$224.05 |
| 60 trading days | US$167.98 | US$102.76 – US$274.62 |
| 90 trading days | US$178.29 | US$97.65 – US$325.50 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Twist Bioscience Corp
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc and Lilly TuneLab. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Financials
- Revenue (TTM)
- $431.80M
- EBITDA
- $-115.28M
- Profit Margin
- -31.66%
- ROE (TTM)
- -29.59%
- EPS (Diluted)
- -2.23
- Book Value
- 7.11
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About TWST.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| ZVZZT | NASDAQ TEST STOCK | $25.25 | +83.24% |
| PRSO | Peraso Inc | $0.59 | +54.13% |
| ATGL | Alpha Technology Group Limited Ordinary Shares | $6.93 | +52.64% |
| BRZE | Braze Inc | $45.57 | +51.70% |
| NVNIF | Nvni Group Limited | $0.06 | +46.83% |
| AIXI | XIAO-I Corporation | $3.10 | +40.91% |
| LESLQ | Leslie's, Inc. | $0.04 | +38.75% |
| FRTT | Fort Technology Inc. | $0.71 | +32.63% |
TWST.US news timeline
6 articles covering TWST.US, most recent first
Latest